CN117653568A - Anti-aging composition and application thereof - Google Patents
Anti-aging composition and application thereof Download PDFInfo
- Publication number
- CN117653568A CN117653568A CN202311701745.6A CN202311701745A CN117653568A CN 117653568 A CN117653568 A CN 117653568A CN 202311701745 A CN202311701745 A CN 202311701745A CN 117653568 A CN117653568 A CN 117653568A
- Authority
- CN
- China
- Prior art keywords
- aging
- yeast extract
- aging composition
- bakuchiol
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000003712 anti-aging effect Effects 0.000 title claims abstract description 61
- 239000000203 mixture Substances 0.000 title claims abstract description 38
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 claims abstract description 64
- 239000012138 yeast extract Substances 0.000 claims abstract description 56
- 229940041514 candida albicans extract Drugs 0.000 claims abstract description 55
- LFYJSSARVMHQJB-UHFFFAOYSA-N Backuchiol Natural products CC(C)=CCCC(C)(C=C)C=CC1=CC=C(O)C=C1 LFYJSSARVMHQJB-UHFFFAOYSA-N 0.000 claims abstract description 37
- LFYJSSARVMHQJB-GOSISDBHSA-N bakuchinol Natural products CC(C)=CCC[C@@](C)(C=C)C=CC1=CC=C(O)C=C1 LFYJSSARVMHQJB-GOSISDBHSA-N 0.000 claims abstract description 37
- LFYJSSARVMHQJB-QIXNEVBVSA-N bakuchiol Chemical compound CC(C)=CCC[C@@](C)(C=C)\C=C\C1=CC=C(O)C=C1 LFYJSSARVMHQJB-QIXNEVBVSA-N 0.000 claims abstract description 37
- KXXXNMZPAJTCQY-UHFFFAOYSA-N bakuchiol Natural products CC(C)CCCC(C)(C=C)C=Cc1ccc(O)cc1 KXXXNMZPAJTCQY-UHFFFAOYSA-N 0.000 claims abstract description 37
- 229940117895 bakuchiol Drugs 0.000 claims abstract description 37
- 244000124209 Crocus sativus Species 0.000 claims abstract description 18
- 235000015655 Crocus sativus Nutrition 0.000 claims abstract description 18
- 241000226555 Leontopodium Species 0.000 claims abstract description 15
- 238000000034 method Methods 0.000 claims abstract description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 44
- 238000000855 fermentation Methods 0.000 claims description 36
- 230000004151 fermentation Effects 0.000 claims description 36
- 241000235342 Saccharomycetes Species 0.000 claims description 24
- 239000000469 ethanolic extract Substances 0.000 claims description 19
- 238000002360 preparation method Methods 0.000 claims description 18
- 241000196324 Embryophyta Species 0.000 claims description 14
- 238000002156 mixing Methods 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 238000000605 extraction Methods 0.000 claims description 11
- 230000002829 reductive effect Effects 0.000 claims description 11
- 239000006071 cream Substances 0.000 claims description 7
- 238000004108 freeze drying Methods 0.000 claims description 7
- 230000032683 aging Effects 0.000 claims description 6
- 238000002604 ultrasonography Methods 0.000 claims description 4
- 239000006210 lotion Substances 0.000 claims description 2
- 235000004727 Opuntia ficus indica Nutrition 0.000 claims 1
- 240000009297 Opuntia ficus-indica Species 0.000 claims 1
- 230000001580 bacterial effect Effects 0.000 claims 1
- 239000000686 essence Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 30
- 102000005936 beta-Galactosidase Human genes 0.000 abstract description 20
- 108010005774 beta-Galactosidase Proteins 0.000 abstract description 20
- 230000037303 wrinkles Effects 0.000 abstract description 17
- 241000219357 Cactaceae Species 0.000 abstract description 15
- 240000004808 Saccharomyces cerevisiae Species 0.000 abstract description 14
- 230000037394 skin elasticity Effects 0.000 abstract description 14
- -1 DPPH free radical Chemical class 0.000 abstract description 7
- 230000032677 cell aging Effects 0.000 abstract description 5
- 230000002195 synergetic effect Effects 0.000 abstract description 4
- 230000008569 process Effects 0.000 abstract description 3
- 230000003064 anti-oxidating effect Effects 0.000 abstract description 2
- 230000000052 comparative effect Effects 0.000 description 34
- 239000000243 solution Substances 0.000 description 33
- 210000003491 skin Anatomy 0.000 description 31
- 238000012360 testing method Methods 0.000 description 30
- 229960004275 glycolic acid Drugs 0.000 description 25
- 241000252212 Danio rerio Species 0.000 description 21
- 239000000126 substance Substances 0.000 description 20
- 239000007788 liquid Substances 0.000 description 16
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 13
- 150000003254 radicals Chemical class 0.000 description 12
- 235000019441 ethanol Nutrition 0.000 description 10
- 238000002835 absorbance Methods 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 102000008186 Collagen Human genes 0.000 description 8
- 108010035532 Collagen Proteins 0.000 description 8
- 241000282414 Homo sapiens Species 0.000 description 8
- 229920001436 collagen Polymers 0.000 description 8
- 235000013399 edible fruits Nutrition 0.000 description 8
- 239000000839 emulsion Substances 0.000 description 8
- 230000005764 inhibitory process Effects 0.000 description 8
- 230000002000 scavenging effect Effects 0.000 description 8
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 238000011081 inoculation Methods 0.000 description 5
- 239000011159 matrix material Substances 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 4
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 230000012447 hatching Effects 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000001815 facial effect Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 230000007794 irritation Effects 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 229940124597 therapeutic agent Drugs 0.000 description 3
- 238000002137 ultrasound extraction Methods 0.000 description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 241001249542 Leonia <angiosperm> Species 0.000 description 2
- 230000002292 Radical scavenging effect Effects 0.000 description 2
- 241001052560 Thallis Species 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 210000004207 dermis Anatomy 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 210000002257 embryonic structure Anatomy 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 238000005286 illumination Methods 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000013011 mating Effects 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 230000001603 reducing effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000011607 retinol Substances 0.000 description 2
- 229960003471 retinol Drugs 0.000 description 2
- 235000020944 retinol Nutrition 0.000 description 2
- 239000011769 retinyl palmitate Substances 0.000 description 2
- 229940108325 retinyl palmitate Drugs 0.000 description 2
- 235000019172 retinyl palmitate Nutrition 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- 230000008591 skin barrier function Effects 0.000 description 2
- 210000004927 skin cell Anatomy 0.000 description 2
- 210000001626 skin fibroblast Anatomy 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000516 sunscreening agent Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 241001247197 Cephalocarida Species 0.000 description 1
- 241001337994 Cryptococcus <scale insect> Species 0.000 description 1
- 241001136860 Ficus tikoua Species 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- 241000207925 Leonurus Species 0.000 description 1
- 206010028164 Multiple allergies Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 240000001439 Opuntia Species 0.000 description 1
- 206010034972 Photosensitivity reaction Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 229940061720 alpha hydroxy acid Drugs 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 208000030172 endocrine system disease Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000004720 fertilization Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- HKBCJQLNYLWIML-UHFFFAOYSA-N icosan-9-yl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OC(CCCCCCCC)CCCCCCCCCCC HKBCJQLNYLWIML-UHFFFAOYSA-N 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 208000033065 inborn errors of immunity Diseases 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 230000002132 lysosomal effect Effects 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 239000008204 material by function Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229930003658 monoterpene Natural products 0.000 description 1
- 235000002577 monoterpenes Nutrition 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 229940127234 oral contraceptive Drugs 0.000 description 1
- 239000003539 oral contraceptive agent Substances 0.000 description 1
- 230000016087 ovulation Effects 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 208000007578 phototoxic dermatitis Diseases 0.000 description 1
- 231100000018 phototoxicity Toxicity 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 230000008470 skin growth Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- 238000009777 vacuum freeze-drying Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/82—Preparation or application process involves sonication or ultrasonication
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Emergency Medicine (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Dermatology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Cosmetics (AREA)
Abstract
The invention provides an anti-aging composition and application thereof, and belongs to the technical field of skin care products. The anti-aging composition provided by the invention has excellent anti-aging effect through the synergistic effect of the yeast extract, the glycollic acid and the bakuchiol, and can effectively reduce the activity of beta-galactosidase in cells and inhibit cell aging; can also effectively remove DPPH free radical and hydroxyl free radical, and can remarkably improve skin elasticity and reduce wrinkles. According to the invention, the alpine leontopodium herb, the crocus sativus and the cactus are added in the yeast culture process, so that the antioxidation effect of the yeast extract is further improved.
Description
Technical Field
The invention relates to the technical field of skin care products, in particular to an anti-aging composition and application thereof.
Background
The skin is an important organ of human body with various physiological functions, and can protect the human body from external environment, prevent internal moisture and useful components from flowing out, regulate body temperature, etc. Since skin is often exposed to various external stimuli, skin is susceptible to wrinkles as compared to other organs. And the facial skin is directly exposed to sunlight, dry environment and pollutants for a longer time, and aging phenomena such as wrinkles and the like occur earlier than the skin which is not exposed to the outside. The most typical changes caused by skin tissue aging are changes in the matrix of the skin (matrix), where human skin fibroblasts (human skin fibroblast) in the dermis layer age, decreasing the ability to produce fibers and matrix, and the overall decrease in the amount of matrix, thinning the skin, decreasing skin elasticity, and forming wrinkles. In addition, skin aging may cause a decrease in skin elasticity, blood circulation disorder, weakening of skin barrier, and the like.
Currently, the most representative anti-aging functional materials used to reduce skin wrinkles and enhance skin elasticity are retinoids, vitamin C, collagen peptides, and the like. Among retinoids, retinoic acid is used as a potent anti-aging therapeutic agent, but has strong irritation to skin, and thus is limitedly used as a therapeutic agent, and retinol, retinol palmitate, etc. having relatively low irritation are widely used as cosmetic materials. However, when retinol and retinol palmitate are irradiated with light, phototoxicity, which causes irritation to the skin, and stability thereof become problems due to denaturation by light. Although vitamin C is also a widely used therapeutic agent for improving wrinkles, it has disadvantages of skin irritation and low stability caused by strong acidity. The collagen peptide can supplement collagen required by skin, maintain skin elasticity, and play a good role in improving skin sagging, but the effect of applying the collagen peptide is not great, and the generated skin wrinkles can be alleviated only by injecting the collagen or the reduced skin matrix components or cells can be supplemented to improve the generated skin wrinkles, but the injection of the collagen is expensive.
Disclosure of Invention
Accordingly, the invention aims to provide an anti-aging composition and application thereof, wherein the anti-aging composition can effectively delay cell aging, improve wrinkles, make skin finer and tighter, and effectively keep skin healthy.
In order to achieve the above object, the present invention provides the following technical solutions:
the invention provides an anti-aging composition, which comprises the following components in parts by weight: 1 to 10 parts of yeast extract, 0.1 to 1 part of glycollic acid and 0.01 to 0.2 part of bakuchiol.
Preferably, the anti-aging composition comprises the following components in parts by weight: 3 to 8 parts of yeast extract, 0.2 to 0.7 part of glycollic acid and 0.75 to 0.15 part of bakuchiol.
Preferably, the preparation method of the yeast extract comprises the following steps:
(1) Adding a plant preparation into a fermentation medium, and inoculating saccharomycetes for fermentation;
(2) Separating thallus and fermentation liquor, mixing thallus with ethanol solution, extracting for 2-4 h at 25-30 ℃ to obtain ethanol extract;
(3) Concentrating the ethanol extract under reduced pressure at 43-47 ℃, and freeze-drying to obtain the yeast extract.
Preferably, the plant preparation comprises alpine leontopodium herb, crocus sativus and cactus, wherein the weight ratio of the alpine leontopodium herb to the crocus sativus to the cactus is 1 (1-3) (0.5-2); the addition amount of the plant preparation is 10-15 g/L.
Preferably, the temperature of the fermentation is 33-37 ℃, and the time of the fermentation is 48-72 hours.
Preferably, the volume fraction of the ethanol solution is 70-80%, and the weight ratio of the thalli to the ethanol solution is 1:1.5-2.5.
Preferably, the extraction is accompanied by ultrasound, the power of which is 200-300W, and the frequency of which is 20-40 kHZ.
The invention also provides application of the anti-aging composition in preparing skin care products.
Preferably, the weight percentage of the anti-aging composition is 0.5-5%.
Preferably, the skin care product comprises moisturizing water, toner, astringent, toner, emulsion, face cream, eye cream, facial mask, essence, essential oil, barrier cream or sun cream.
By adopting the technical scheme, the invention has the following beneficial effects: the anti-aging composition provided by the invention has excellent anti-aging effect through the synergistic effect of the yeast extract, the glycollic acid and the bakuchiol, and can effectively reduce the activity of beta-galactosidase in cells and inhibit cell aging; can also effectively remove DPPH free radical and hydroxyl free radical, and can remarkably improve skin elasticity and reduce wrinkles. According to the invention, the alpine leontopodium herb, the crocus sativus and the cactus are added in the yeast culture process, so that the antioxidation effect of the yeast extract is further improved.
Detailed Description
The invention provides an anti-aging composition, which comprises the following components in parts by weight: 1 to 10 parts of yeast extract, 0.1 to 1 part of glycollic acid and 0.01 to 0.2 part of bakuchiol.
In the anti-aging composition, the weight part of the yeast extract is 1 to 10 parts, more preferably 3 to 8 parts, still more preferably 5 parts;
the weight part of the glycollic acid is 0.1 to 1 part, more preferably 0.2 to 0.7 part, and still more preferably 0.3 part;
the weight part of the bakuchiol is 0.01-0.2 part, more preferably 0.075-0.15 part, and still more preferably 0.1 part.
Glycolic acid, which includes fruit acid or alpha-hydroxy acid, is a natural product isolated from sucrose; citric acid from oranges and other citrus fruits can also be classified as glycolic acid. Glycolic acid can remove dead skin cells and excess grease and stimulate fibroblasts in the dermis to produce more collagen.
The bakuchiol is a monoterpene compound separated from the bakuchiol of leguminous plants, can control oil and resist acne, inhibit bacteria and inflammation, improve pigmentation, and has the effects of resisting oxidation and aging, reducing fine lines and wrinkles, stimulating collagen regeneration, enhancing skin elasticity and compactness, preventing ultraviolet rays from damaging skin, and delaying apoptosis of cells.
The yeast extract is prepared by breaking cell wall of yeast, extracting protein, nucleic acid, vitamins, etc., and performing biological enzymolysis to obtain natural active ingredients rich in small molecular amino acids, peptides, nucleotides, vitamins, etc. Wherein, the amino acid content is more than 30%, the total protein is more than 50%, and the nucleotide is more than 10%, and the product has the functions of moisturizing, diminishing inflammation, resisting oxidation and aging.
In the present invention, the preparation method of the yeast extract comprises the following steps:
(1) Adding a plant preparation into a fermentation medium, and inoculating saccharomycetes for fermentation;
(2) Separating thallus and fermentation liquor, mixing thallus with ethanol solution, extracting for 2-4 h at 25-30 ℃ to obtain ethanol extract;
(3) Concentrating the ethanol extract under reduced pressure at 43-47 ℃, and freeze-drying to obtain the yeast extract.
In the invention, a plant preparation is added into a fermentation medium, and yeast is inoculated for fermentation; the fermentation medium is preferably LB fermentation medium, and the yeast is activated before inoculation, so that the invention has no special limit on the activation of the yeast and can achieve the purpose of activating the thallus. After activating the saccharomycetes, inoculating the saccharomycetes for fermentation, wherein the inoculation amount of the saccharomycetes is 5-12%, more preferably 7-10%, and even more preferably 8%; the yeast may be Saccharomyces cerevisiae, cryptococcus, candida, but is not limited thereto.
In the present invention, the plant preparation includes alpine leontopodium herb, crocus sativus and cactus fruit; the radix et caulis Opuntiae Dillenii, stigma croci, and radix et caulis Opuntiae Dillenii are dried radix et rhizoma Rhei-grass, stigma croci, and radix et caulis Opuntiae Dillenii with water content below 12%; the alpine leontopodium herb adopts flowers or leaves of the alpine leontopodium herb, the crocus sativus adopts crocus sativus petals, and the cactus fruit is a cactus fruit. The weight ratio of the alpine leontopodium herb, the crocus sativus and the cactus is 1 (1-3) (0.5-2), more preferably 1 (1.5-2.5) (1-1.5), and more preferably 1:2:8. According to the invention, flowers or leaves of alpine leontopodium herb, crocus sativus and cactus are ground into powder, and the powder is added into a fermentation medium, wherein the mesh number of the powder is 80-120 meshes, more preferably 90-110 meshes, and still more preferably 100 meshes. The alpine leontopodium has the functions of resisting oxidation, scavenging free radicals, strengthening skin barrier, repairing and relieving, whitening and nourishing skin; the crocus sativus contains rich antioxidant substances, so that the damage of free radicals to skin cells can be neutralized, and the skin aging can be prevented; the radix et caulis Opuntiae Dillenii can be used for preventing and treating acne caused by high androgen, and promoting skin growth factor. The addition of the plant preparation further enhances the antioxidant activity of the strain.
In the present invention, the fermentation temperature is 33 to 37 ℃, more preferably 34 to 36 ℃, still more preferably 35 ℃; the fermentation time is 48 to 72 hours, more preferably 55 to 65 hours, still more preferably 60 hours; the fermentation is carried out under stirring conditions, and the stirring speed is 100 to 300rpm, more preferably 150 to 250rpm, still more preferably 200rpm.
After the fermentation is completed, the fermentation product is separated into thalli and fermentation liquor by centrifugation, wherein the rotation speed of the centrifugation is 6000-8000 rpm, more preferably 6500-7500 rpm, and even more preferably 7000rpm; the centrifugation time is 8 to 12 minutes, more preferably 9 to 11 minutes, still more preferably 10 minutes; obtaining saccharomycetes after centrifugation, mixing the saccharomycetes with an ethanol solution for extraction, wherein the volume fraction of the ethanol solution is 70-80%, more preferably 73-78%, still more preferably 75%; the weight ratio of the saccharomycetes to the ethanol solution is 1:1.5-2.5, more preferably 1:1.8-2.2, and still more preferably 1:2; the extraction temperature is 25-30 ℃, more preferably 27-29 ℃, and still more preferably 28 ℃, and the temperature range can protect active ingredients in the strain lysate or culture solution from thermal denaturation; the extraction time is 2 to 4 hours, more preferably 2.5 to 3.5 hours, still more preferably 3 hours; the extraction is accompanied by ultrasound, the power of the ultrasound is 200-300W, more preferably 230-270W, and even more preferably 250W; the frequency of the ultrasonic wave is 20-40 kHZ, more preferably 25-35 kHZ, more preferably 30kHZ, and the purpose of the ultrasonic wave is to generate cavitation effect in the liquid by using strong ultrasonic wave, promote the breaking of bacteria and improve the extraction efficiency. After the extraction is completed, an ethanol extract is obtained.
After the ethanol extract is obtained, the ethanol extract is subjected to reduced pressure concentration, wherein the temperature of the reduced pressure concentration is 43-47 ℃, more preferably 44-46 ℃, and still more preferably 45 ℃; the vacuum degree of the reduced pressure concentration is-0.1 to-0.08 MPa, more preferably-0.095 to-0.085 MPa, and still more preferably-0.09 MPa; the reduced pressure concentration was performed under water bath conditions. Concentrating the ethanol extract to an extract with the density of 1.3-1.7 g/mL, more preferably 1.4-1.6 g/mL, more preferably 1.5g/mL, and freeze-drying after the concentration is finished, wherein the freeze-drying temperature is-35 to-15 ℃, more preferably-30 to-20 ℃, more preferably-25 ℃; the vacuum degree of vacuum freeze-drying is 20 to 40Pa, more preferably 25 to 35Pa, still more preferably 30Pa, to obtain yeast extract.
The invention also provides application of the anti-aging composition in preparing skin care products, wherein the weight percentage of the anti-aging composition is 0.5-5%, more preferably 1-4%, and still more preferably 3%. The skin care product comprises moisturizing water, toner, astringent, skin softening water, lotion, cream, eye cream, facial mask, essence, essential oil, barrier cream or sun cream.
The technical solutions provided by the present invention are described in detail below with reference to examples, but they should not be construed as limiting the scope of the present invention.
Unless otherwise specified, reagents and materials used in the following examples are all commercially available; bakuchiol is purchased from Shanghai Union industries, inc. or self-produced, and glycolic acid is purchased from Hebei Chengxi, inc. or self-produced; the saccharomycete in the embodiment is selected from saccharomycete CCTCCWY2008323 and is purchased from a China center for type culture Collection.
Example 1
Inoculating the saccharomycetes CCTCC WY2008323 into an LB liquid medium, and standing and culturing for 24 hours at 35 ℃ to obtain fully activated saccharomycetes liquid. Inoculating yeast liquid into LB liquid fermentation medium according to 5% of inoculation amount, fermenting at 33 ℃ for 48 hours at 100rpm, adding 10g/L of plant preparation into the LB liquid fermentation medium, mixing dry alpine leonurus leaf, crocus sativus petal and cactus fruit according to the weight ratio of 1:1:0.5, and separating yeast thallus and fermentation liquor at 6000rpm after fermentation.
Mixing saccharomycetes and 70% ethanol solution according to a weight ratio of 1:1.5, performing ultrasonic extraction for 2 hours at 25 ℃, wherein the ultrasonic power is 200W, the frequency is 20kHZ, and obtaining ethanol extract after the extraction is completed. Concentrating the ethanol extract under reduced pressure at-35deg.C and-0.1 MPa, concentrating the ethanol extract to obtain extract with density of 1.3g/mL, and lyophilizing at-35deg.C and 20Pa to obtain yeast extract.
In the anti-aging composition of this example, the yeast extract, glycolic acid and bakuchiol prepared as described above were mixed at a mass ratio of 1:0.1:0.01, and specifically, 1g of the yeast extract, 0.1g of glycolic acid and 0.01g of bakuchiol were mixed.
Example 2
Inoculating the saccharomycetes CCTCC WY2008323 into an LB liquid medium, and standing and culturing for 24 hours at 35 ℃ to obtain fully activated saccharomycetes liquid. Inoculating the saccharomycete liquid into an LB liquid fermentation medium according to the inoculation amount of 8%, fermenting at 35 ℃ for 60 hours at 200rpm, adding 12g/L of plant preparation into the LB liquid fermentation medium, mixing dry alpine leonia leaves, crocus sativus petals and cactus fruits according to the weight ratio of 1:2:1, and separating saccharomycete bodies and fermentation liquor at 7000rpm after the fermentation is finished.
Mixing saccharomycetes and 75% ethanol solution according to a weight ratio of 1:2, carrying out ultrasonic extraction for 3 hours at 28 ℃, wherein the ultrasonic power is 280W, the frequency is 40kHZ, and obtaining ethanol extract after the extraction is completed. Concentrating the ethanol extract under reduced pressure at 45 deg.C and-0.09 MPa, concentrating the ethanol extract to obtain extract with density of 1.5g/mL, and freeze drying at-25deg.C and 30Pa to obtain yeast extract.
In the anti-aging composition of this example, the yeast extract, glycolic acid and bakuchiol prepared as described above were mixed at a mass ratio of 5:0.3:0.1, and specifically, 5g of the yeast extract, 0.3g of glycolic acid and 0.1g of bakuchiol were mixed.
Example 3
Inoculating the saccharomycetes CCTCC WY2008323 into an LB liquid medium, and standing and culturing for 24 hours at 35 ℃ to obtain fully activated saccharomycetes liquid. Inoculating the saccharomycete liquid into an LB liquid fermentation medium according to 12% of inoculation amount, fermenting at 37 ℃ for 72 hours at 300rpm, adding 15g/L of plant preparation into the LB liquid fermentation medium, mixing dry alpine leonia leaves, crocus sativus petals and cactus fruits according to the weight ratio of 1:3:2, and separating saccharomycete bodies and fermentation liquor at 8000rpm after fermentation.
Mixing saccharomycetes and 80% ethanol solution according to a weight ratio of 1:2.5, carrying out ultrasonic extraction for 4 hours at 30 ℃, wherein the ultrasonic power is 400W, the frequency is 30kHZ, and obtaining ethanol extract after the extraction is completed. Concentrating the ethanol extract under reduced pressure at 47 deg.C and-0.1 MPa, concentrating the ethanol extract to obtain extract with density of 1.7g/mL, and freeze drying at-15deg.C and 40Pa to obtain yeast extract.
In the anti-aging composition of this example, the yeast extract, glycolic acid and bakuchiol prepared as described above were mixed at a mass ratio of 10:1:0.2, and specifically, 10g of the yeast extract, 1g of glycolic acid and 0.2g of bakuchiol were mixed.
Experimental example 1 Effect of different anti-aging substances on inhibition ratio of beta-galactosidase in zebra fish
The experimental example prepared various anti-aging substances with different components and contents, and as shown in table 1, the preparation method of the yeast extracts in comparative examples 1, 4, 5, 7 and 8 is the same as that of example 1; the yeast extract of comparative example 9 is different from that of comparative example 1 in that no alpine leontopodium herb leaves, crocus sativus petals and cactus were added during the yeast culture.
TABLE 1 content of anti-aging substances of different Components
Group of | Anti-aging substance component and its content |
Comparative example 1 | Yeast extract 3g |
Comparative example 2 | Glycolic acid 0.3g |
Comparative example 3 | Bakuchiol 0.1g |
Comparative example 4 | Yeast extract 3 g+glycolic acid 0.3g |
Comparative example 5 | Yeast extract 3 g+bakuchiol 0.1g |
Comparative example 6 | Glycolic acid 0.3g and bakuchiol 0.1g |
Comparative example 7 | Yeast extract 1 g+glycolic acid 0.3 g+bakuchiol 0.3g |
Comparative example 8 | Yeast extract 0.5 g+glycolic acid 0.3 g+bakuchiol 0.1g |
Comparative example 9 | Yeast extract 3g |
Example 1 | Yeast extract 1g+0.1g glycolic acid+0.01 g+bakuchiol 0.01g |
Example 2 | Yeast extract 3 g+glycolic acid 0.3 g+bakuchiol0.1g |
Example 3 | Yeast extract 10g+0.2g glycolic acid+0.2 g bakuchiol 0.2g |
Zebra fish is a spinal model organism, which is highly homologous with human beings in gene and protein levels and is quite similar to human beings in terms of development process, organ structure, physiological functions and the like; meanwhile, the aging process of the zebra fish is more similar to that of the human being compared with that of mice and the human being, and based on the characteristics, the anti-aging research is carried out by taking the AB-series zebra fish as an experimental animal, and the AB-series zebra fish is purchased from the aquatic organism research institute of China academy of sciences.
Female and male zebra fish of 6 months of age are separately cultured at 28.5 ℃ under the condition of 14h illumination/10 h darkness, and 2 times of artemia are fed at 10:00 (am) and 4:00 (pm) each day. And (3) the day before the embryo is obtained by mating, putting the healthy mature zebra fish into a mating cylinder according to the proportion of male to female of 1:2, placing a partition board in the middle, and placing the zebra fish in a dark environment. The baffle is drawn out before the next day of lighting, and the light stimulates the female fish to ovulate. Adult fish are fished out half an hour after ovulation, fertilized eggs are collected and sterilized. The fertilized eggs are placed in a constant temperature incubator at 28.5 ℃ and are cultured for 14 hours under illumination/10 hours in the dark period.
AB-line zebra fish 8h (8 hpf) after fertilization were randomly divided into 13 groups of 15 embryos per dish:
the first group was untreated and served as a control group;
the second group is H 2 O 2 Model group, H with final concentration of 0.5mmol/L is added in 72H after hatching of zebra fish 2 O 2 A solution;
the first group added H with the final concentration of 0.5mmol/L within 72H after the hatching of the zebra fish 2 O 2 The content of the anti-aging substances in the solution and the anti-aging substances in the comparative example 1 in the zebra fish culture solution is 10 mug/mL, 25 mug/mL, 50 mug/mL and 100 mug/mL respectively;
the second group adds H with the final concentration of 0.5mmol/L in 72H after the hatching of the zebra fish 2 O 2 The content of the anti-aging substances in the solution and the anti-aging substances in the comparative example 2 in the zebra fish culture solution is respectively 10 mug/mL, 25 mug/mL, 50 mug/mL and 100 mug/mL;
the third group to the eleventh group are respectively added with H with the final concentration of 0.5mmol/L within 72 hours after the hatching of the zebra fish 2 O 2 The solutions and the anti-aging substances of comparative examples 3 to 9 and examples 1 to 3 were such that the content of the anti-aging substances in the zebra fish culture broth was 10. Mu.g/mL, 25. Mu.g/mL, 50. Mu.g/mL, 100. Mu.g/mL, respectively; after each of the above groups was continuously treated in a constant temperature incubator at 28.5℃for 72 hours, embryos were washed with zebra fish culture water, and then the beta-galactosidase activity in zebra fish bodies was detected using a beta-galactosidase activity detection kit (Beijing Box Biotechnology Co., ltd.) according to the instructions, and the inhibition ratio of the beta-galactosidase activity was calculated using the following formula, and the results are shown in Table 2.
Wherein A1 is the activity of beta-galactosidase in zebra fish bodies of a control group;
a2 is the activity of beta-galactosidase in the zebra fish body of the model group;
a3 is the activity of beta-galactosidase in the zebra fish body added with anti-aging substances in the culture solution;
TABLE 2 inhibition of beta-galactosidase Activity by different groups of anti-aging substances
Beta-galactosidase (SA-beta-Gal) is a lysosomal hydrolase that is expressed only in senescent cells to catalyze the hydrolysis of beta-galactoside, the increase in activity being a significant feature of cell aging. As is clear from Table 2, the yeast extract, glycolic acid and bakuchiol all had an inhibitory effect on beta-galactosidase in the concentration range of 10 to 100. Mu.g/mL, and the inhibitory effect was enhanced with increasing concentration. The yeast extract of comparative example 9 has a lower beta-galactosidase activity than comparative example 1, demonstrating that the addition of alpine leontopodium herb, crocus sativus and opuntia ficus tikoua during the yeast culture can increase the inhibition of beta-galactosidase by the yeast extract.
As is clear from comparative examples 1 to 3 and comparative examples 7 to 8, the inhibition ratio of the anti-aging substance consisting of yeast extract, glycolic acid, bakuchiol to the beta-galactosidase activity was higher than the sum of the inhibition ratios of the individual actions of yeast extract, glycolic acid, bakuchiol. As is clear from comparative examples 4 to 6 and comparative examples 7 to 8, the effect of inhibiting beta-galactosidase was increased by combining the yeast extract, glycolic acid and bakuchiol in two pairs, but was lower than the effect of combining the three. It can be seen that the combination of the yeast extract, the glycollic acid and the bakuchiol can synergistically inhibit the increase of beta-galactosidase and inhibit cell aging. As is clear from comparative examples 7 to 8 and examples 1 to 3, although the anti-aging compositions of comparative examples 7 to 8 comprise three components of yeast extract, glycolic acid and bakuchiol, the ratio of the three components is not within the scope of the present invention, and the inhibition effect on beta-galactosidase is not as good as that of examples 1 to 3 of the present invention.
In conclusion, the anti-aging composition prepared by compounding the yeast extract, the glycollic acid and the bakuchiol has an inhibition effect on beta-galactosidase, the drug effect is superior to the effect of single use of each component or the superposition of the two components by matching, the anti-aging composition has a remarkable synergistic effect, and the anti-aging effect is optimal when the weight ratio of the yeast extract to the glycollic acid to the bakuchiol is within the range of (1-10): (0.1-1): (0.01-0.2).
Experimental example 2 scavenging test of free radical by different anti-aging substances
The experimental samples used in this experimental example were prepared in the same manner as in experimental example 1, and the anti-aging substances of examples 1 to 3 and comparative examples 1 to 9 were tested for radical scavenging ability
Test sample: examples 1 to 3 and comparative examples 1 to 8 as antiaging substances
(1) Determination of the scavenging Capacity of 1, 1-diphenyl-2-trinitrobenzene liver (DPPH) free radical
Reagent: 1, 1-diphenyl-2-trinitroskin and absolute ethyl alcohol.
Preparing a test sample: 10mg of the anti-aging substances of examples 1 to 3 and comparative examples 1 to 9 were taken out, respectively, and dissolved with absolute ethanol to a volume of 200mL for use.
The testing method comprises the following steps: accurately sucking 2.0mL of the prepared test sample and 2.0mL of the LDPPH solution, placing the test sample and the solution into a test tube, vibrating and uniformly mixing, and placing the test sample and the solution into an incubator to be kept at the constant temperature of 37 ℃ for 1h. Accurately sucking 2.0mL of prepared test sample and 2.0mL of absolute ethyl alcohol by taking absolute ethyl alcohol as a blank control, placing the test sample and the 2.0mL of absolute ethyl alcohol into a test tube, vibrating and uniformly mixing, and then placing the test sample and the test tube into a constant temperature box for constant temperature 1h at 37 ℃; accurately sucking 2.0mL of the prepared DPPH solution and 2.0mL of absolute ethyl alcohol, placing into a test tube, shaking and mixing uniformly, and then placing into a constant temperature box for constant temperature 1h at 37 ℃. Each sample was tested for absorbance at 517 nm.
Clearance (%) = [1- (a) x -A j )/A c ]X 100%; wherein A is c Absorbance of 2.0mL DPPH solution and 2.0mL absolute ethanol mixed solution; a is that x Absorbance of 2.0mL test sample and 2.0mL DPPH solution mixture; a is that j The absorbance was 2.0mL of the test sample and 2.0mL of the absolute ethanol mixed solution. Three replicates were tested for each set of samples and averaged, the results are shown in table 3.
(2) Determination of the scavenging Capacity for hydroxyl radicals (. OH)
Reagent: 2mmol/L FeSO 4 Solution, 1mmol/LH 2 O 2 Solution, 6mmol/L salicylic acid solution.
10mg of the anti-aging substances of examples 1 to 3 and comparative examples 1 to 8 were taken respectively, dissolved with water and fixed to 200mL.
And (3) preparation of a reagent: 3mL of FeSO with a concentration of 2mmol/L are added into a test tube in sequence 4 Solution, 3mL H with concentration of 1mmol/L 2 O 2 The solution is shaken up, then 3mL of salicylic acid solution with the concentration of 6mmol/L is added, and the solution is shaken up; heating in 37deg.C water bath for 15min, and taking out.
The testing method comprises the following steps: measuring the absorbance of the formulated reagent; adding the prepared test sample, shaking uniformly, heating in water bath for 15min, taking out, and measuring absorbance; water was used as a blank.
Clearance (%) = [ a n -A m -(A n -A k )]/A k X 100%; wherein An is the absorbance of the formulated reagent, A m To add absorbance after test sample has been cleared of OH, A k Absorbance was used as a blank. Three replicates were tested for each set of samples and averaged, the results are shown in table 3.
TABLE 3 scavenging of free radicals by different groups of anti-aging substances
As shown in Table 3, the yeast extract, the glycollic acid and the bakuchiol have the effect of scavenging DPPH free radicals and hydroxyl free radicals, but the scavenging rate of the combination of the yeast extract, the glycollic acid and the bakuchiol on the DPPH free radicals and the hydroxyl free radicals is superior to the superposition of the independent use of each component or the combination of the two components, which indicates that the yeast extract, the glycollic acid and the bakuchiol are compounded, and the components are synergistic mutually, so that the composition has better scavenging efficiency on the free radicals and further has more excellent anti-aging effect. Meanwhile, as is clear from comparative examples 1 and 9, the addition of alpine leontopodium herb, crocus sativus and cactus fruit during the yeast culture can improve the radical scavenging rate of the yeast extract.
Experimental example 3 measurement of skin improvement Effect
Comparative example 10
The yeast extract of example 1 was replaced with the yeast extract prepared in comparative example 9, and the contents of the yeast extract, glycolic acid and bakuchiol were the same as in example 1.
The anti-aging compositions of examples 1 to 3 and comparative examples 7, 8, and 10 were prepared into emulsions according to the following system:
the emulsion comprises the following components in percentage by weight: 1% of an anti-aging composition, 15% of dipropylene glycol, 7.5% of octyl dodecanol myristate, 3% of carbomer, 10% of glycerol, 6% of allantoin, 2.5% of xanthan gum, 3% of beeswax, 5% of glycerol stearate and the balance of water.
The test was performed by randomly extracting 60 skin-healthy volunteers, one group of 10 persons, each group being a unit, corresponding to the emulsions of comparative examples 7 to 9 of test examples 1 to 3, respectively, and the test results were all the average value of each group.
Inclusion volunteer criteria were: women aged 30-50 years; those who have not used hormonal drugs and immunosuppressants for nearly 30 days; the tested part does not participate in other clinical trial persons within 30 days; during the test, it was agreed that no cosmetics, drugs and health products having an influence on the results were used.
Exclusion criteria: those with open wounds or erosive surfaces; highly allergic constitution; pregnancy, lactation or pregnancy-preparing person during testing; has severe barycenter, liver and kidney function injury and severe hypoimmunity; patients with mental diseases and severe endocrine diseases and patients with oral contraceptives; clinical testers or other testers taking medicines within 30 days, or those who have medicines with systematic effects on test results within nearly 1 week; within 2 weeks there were cosmetic products that could have an effect on the test results for oral and topical use.
Abort and exit criteria: smearing the tested sample or performing a return visit record according to the requirement in the test period; during use, suffering from serious diseases or suffering from serious adverse reactions.
The testing method comprises the following steps: after the volunteers cleansing the face in the morning and evening each day, the skin elasticity and wrinkles were measured before and after the experiment, respectively, using the above emulsion on the whole face for 30 consecutive days.
Skin elasticity was measured by using a skin elasticity tester Cutometer dual MPA from CK company, germany, and wrinkles were detected by using a visual skin detector and automatically analyzed to calculate the skin elasticity improvement rate and the wrinkle removal rate, and the test results are shown in table 4.
TABLE 4 improvement of skin by emulsions of different groups
As can be seen from Table 4, the emulsion prepared from the anti-aging composition of the present invention has the effect of remarkably improving skin elasticity and reducing wrinkles, and has the best effect of improving skin when the weight ratio of the yeast extract, the glycolic acid and the bakuchiol is (1-10): 0.1-1): 0.01-0.2; the emulsion prepared in comparative example 10 had a lower effect on improving skin than examples 1 to 3 and comparative examples 7 and 8, indicating that the addition of alpine leontopodium herb, crocus sativus and cactus during yeast culture can further improve skin elasticity and reduce wrinkles.
From the above examples, the present invention provides an anti-aging composition and its use. The anti-aging composition provided by the invention can effectively reduce the activity of beta-galactosidase, remove free radicals, improve skin elasticity and reduce wrinkles.
The foregoing is merely a preferred embodiment of the present invention and it should be noted that modifications and adaptations to those skilled in the art may be made without departing from the principles of the present invention, which are intended to be comprehended within the scope of the present invention.
Claims (10)
1. An anti-aging composition is characterized by comprising the following components in parts by weight: 1 to 10 parts of yeast extract, 0.1 to 1 part of glycollic acid and 0.01 to 0.2 part of bakuchiol.
2. The aging composition according to claim 1, comprising the following components in parts by weight: 3 to 8 parts of yeast extract, 0.2 to 0.7 part of glycollic acid and 0.75 to 0.15 part of bakuchiol.
3. The anti-aging composition according to claim 1 or 2, wherein the method for preparing the yeast extract comprises the steps of:
(1) Adding a plant preparation into a fermentation medium, and inoculating saccharomycetes for fermentation;
(2) Separating thallus and fermentation liquor, mixing thallus with ethanol solution, extracting for 2-4 h at 25-30 ℃ to obtain ethanol extract;
(3) Concentrating the ethanol extract under reduced pressure at 43-47 ℃, and freeze-drying to obtain the yeast extract.
4. The anti-aging composition according to claim 3, wherein the plant preparation comprises alpine leontopodium herb, crocus sativus and opuntia ficus-indica in a weight ratio of 1 (1-3): 0.5-2; the addition amount of the plant preparation is 10-15 g/L.
5. An anti-ageing composition according to claim 3, wherein the fermentation is carried out at a temperature of 33-37 ℃ for a period of 48-72 hours.
6. The anti-aging composition according to claim 3, wherein the volume fraction of the ethanol solution is 70-80%, and the weight ratio of the bacterial cells to the ethanol solution is 1:1.5-2.5.
7. The anti-aging composition according to claim 3, wherein the extraction is accompanied by ultrasound, the power of which is 200-300W, and the frequency of which is 20-40 kHZ.
8. Use of an anti-aging composition according to any one of claims 1 to 7 in the preparation of a skin care product.
9. The use according to claim 8, wherein the anti-aging composition is present in the skin care product in an amount of 0.5 to 5% by mass.
10. The use according to claim 8, wherein the skin care product comprises water, lotion, cream, essence or mask products.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311701745.6A CN117653568A (en) | 2023-12-12 | 2023-12-12 | Anti-aging composition and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311701745.6A CN117653568A (en) | 2023-12-12 | 2023-12-12 | Anti-aging composition and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN117653568A true CN117653568A (en) | 2024-03-08 |
Family
ID=90071195
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311701745.6A Pending CN117653568A (en) | 2023-12-12 | 2023-12-12 | Anti-aging composition and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117653568A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN118593400A (en) * | 2024-06-18 | 2024-09-06 | 广东丹兰国际生物科技有限公司 | An anti-wrinkle and anti-aging composition containing traditional Chinese medicine ingredients and its preparation method and application |
-
2023
- 2023-12-12 CN CN202311701745.6A patent/CN117653568A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN118593400A (en) * | 2024-06-18 | 2024-09-06 | 广东丹兰国际生物科技有限公司 | An anti-wrinkle and anti-aging composition containing traditional Chinese medicine ingredients and its preparation method and application |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101373636B1 (en) | Composition for improving condition of skin and scalp containing fermented extracts of herb mixture | |
CN110464693A (en) | Composition for splitting yeast tunning lysis object containing two and preparation method thereof and the application in cosmetics | |
CN110882207B (en) | A kind of preparation technology and method of essence for skin repair | |
JP2011505353A (en) | Skin external preparation composition containing a compound herbal extract as an active ingredient | |
CN111544371B (en) | Whitening Repair Mask with Probiotic Active Extract and Niacinamide | |
CN103585097A (en) | Epidermal growth factor-loaded bletilla rhizome polysaccharide compound, and preparation method and application thereof | |
CN108815072A (en) | A kind of plant composition fermentation magma and its preparation method and application | |
CN112535652A (en) | Light sensation activation stock solution and preparation method thereof | |
CN108670933B (en) | Skin care composition with moisturizing, whitening and anti-aging functions and application thereof | |
TW202102239A (en) | Antiaging agent, antioxidant, antiinflammatory agent and whitening agent, and cosmetic | |
CN111265441A (en) | Composition capable of enhancing skin night repair and regeneration capacity and application thereof | |
CN117653568A (en) | Anti-aging composition and application thereof | |
CN111419733A (en) | Ceramide polypeptide compound Anmyo honey | |
CN113101256B (en) | Anti-aging repair nanoemulsion and application thereof | |
CN108066210B (en) | A herba Hyperici Japonici leaf fermented product using domestic fungus, and its preparation method and application | |
KR102300581B1 (en) | Compositions for improving skin conditions comprising plant extracts or fractions thereof | |
KR101286266B1 (en) | Composition for hair loss prevention and/or hair growth promotion comprising fermented pruni cortex | |
KR102054100B1 (en) | Cosmetic composition containing fermented extract of roots | |
CN115054566B (en) | Scalp aging resisting composition and preparation method thereof | |
CN116807947A (en) | Anti-aging skin conditioner and application thereof | |
KR102374056B1 (en) | Natural mixture for improving health and functional cosmetic and shampoo agent including the same for preventing hair loss | |
WO2023030041A1 (en) | Type i collagen production accelerant | |
CN111053721B (en) | Silky glowing eye cream and preparation method thereof | |
TWI754137B (en) | Angelica dahurica ferment, preparation method thereof and use thereof for improving skin appearance | |
CN115414313A (en) | Anti-aging composition containing micrococcus lysate and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |